Nino, Giesel S.

HRN: 22-57-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
CEFUROXIME 500MG (TAB)
02/06/2023
02/13/2023
PO
500 Mg
BID
2 Degree RMLE
Waiting Final Action 
10/25/2024
CEFUROXIME 500MG (TAB)
10/25/2024
10/31/2024
ORAL
500 Mg
BID
Postpartum Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: